about
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...
Read More
7.08
-0.22
(-3.01%)
1.7M
XNAS Volume
XNAS 16 Jan, 2026 3:38 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Replimune Grp Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..